Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Affect Therapeutics has developed and commercialized a fully digital platform for the treatment of substance use disorders and mental health conditions. Their approach combines contingency management (financial incentives for healthy behaviors), cognitive behavioral therapy, medication-assisted treatment when appropriate, and peer support—all delivered via a secure mobile app. The company has demonstrated positive clinical pilot results since 2021 and expanded rapidly across the United States with programs for multiple substance use disorders as well as general mental health care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Affect Therapeutics.